AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Revenio Group Oyj

Regulatory Filings Dec 15, 2014

3236_rns_2014-12-15_ed433c79-615f-40d1-af33-b0cdad61b5eb.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

Disclosure 320040

Revenio Group Oyj - Company Announcement

Revenio Group Corporation: BOOMERANGER BOATS RECEIVED AN ORDER OF 2.3 MILLION

Revenio Group Corporation Stock Exchange Release, December 15, 2014 at 9:00 am BOOMERANGER BOATS RECEIVED AN ORDER OF 2.3 MILLION Boomeranger Boats Oy, representing Revenio Group's Technology and Services segment, has received an order of 2.3 million euros from United Arab Emirates. According to the agreement, Boomeranger Boats will deliver the customer two RIB special boats designed for demanding conditions by November 2015. The received order has approximately 8 months effect on employment and the current layoffs will be cancelled gradually by February 2015. As part of Revenio Group's strategic focus on Health Tech, Boomeranger Boats has been transferred to available-for-sale discontinued operations. In operational terms, the company will continue to operate as usual and the arrangement does not have an effect on the current or future customer relationships. Revenio Group Oyj Olli-Pekka Salovaara President and CEO Further information: President and CEO Olli-Pekka Salovaara, tel +358 40-5675520 [email protected] www.revenio.fi DISTRIBUTION: NASDAQ OMX Helsinki Financial Supervisory Authority (FIN-FSA) Principal media www.revenio.fi The Revenio Group in brief Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy and Oscare Medical Oy. The widely patented Icare product family is the current cornerstone of the Group's success. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. The Revenio Group also includes other business operations, which are grouped under the Technology and Services segment. This segment's operations have a shared global market and represent the cutting edge of technology products and services in their industry. In 2013, the Revenio Group's net sales totaled EUR 25.7 million, with itsoperating margin standing at 21.7%. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki. [HUG#1880016]

Talk to a Data Expert

Have a question? We'll get back to you promptly.